TegoScience Inc
TegoScience Inc. produces and sells wound-healing skin cell therapy products from human epithelial cells in South Korea. The company's products include Holoderm, Kaloderm, and Rosmir. It also provides Neoderm, contract research, and Skinbank services. The company was founded in 2001 and is based in Seoul, South Korea.
TegoScience Inc (191420) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.014x
Based on the latest financial reports, TegoScience Inc (191420) has a cash flow conversion efficiency ratio of -0.014x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-824.41 Million) by net assets (₩57.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
TegoScience Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how TegoScience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
TegoScience Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TegoScience Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Effecten-Spiegel AG
STU:EFS
|
N/A |
|
CB Industrial Product Holding
KLSE:7076
|
0.028x |
|
Allcargo Logistics Limited
NSE:ALLCARGO
|
0.171x |
|
ASTRO-MED INC. DL-01
F:AZO
|
N/A |
|
Thailand Prime Property Freehold and Leasehold Real Estate Investment Trust
BK:TPRIME
|
0.008x |
|
Instabank ASA
OL:INSTA
|
N/A |
|
ESAF Small Finance Bank
NSE:ESAFSFB
|
-0.368x |
|
Emperor Energy Ltd
AU:EMP
|
-0.062x |
Annual Cash Flow Conversion Efficiency for TegoScience Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of TegoScience Inc from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩49.86 Billion | ₩-1.16 Billion | -0.023x | -35.59% |
| 2023-12-31 | ₩46.33 Billion | ₩-794.61 Million | -0.017x | -180.12% |
| 2022-12-31 | ₩48.60 Billion | ₩1.04 Billion | 0.021x | +126.95% |
| 2021-12-31 | ₩48.47 Billion | ₩457.25 Million | 0.009x | -63.89% |
| 2020-12-31 | ₩48.99 Billion | ₩1.28 Billion | 0.026x | +2916.76% |
| 2019-12-31 | ₩47.82 Billion | ₩41.40 Million | 0.001x | -95.15% |
| 2018-12-31 | ₩46.68 Billion | ₩833.88 Million | 0.018x | -77.74% |
| 2017-12-31 | ₩35.71 Billion | ₩2.87 Billion | 0.080x | -11.57% |
| 2016-12-31 | ₩25.98 Billion | ₩2.36 Billion | 0.091x | -13.13% |
| 2015-12-31 | ₩25.21 Billion | ₩2.63 Billion | 0.104x | -- |